The highest CRP was present in NAFLD patients (16.7 ± 6.8 mg/L), followed by non-NAFLD patients (4.6 ± 0.9 mg/L) and controls (1.2 ± 0.9 mg/L). The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.